Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2023-09-01
|
| Serija: | Blood Cancer Journal |
| Online dostop: | https://doi.org/10.1038/s41408-023-00923-6 |
| Oznake: |
Brez oznak, prvi označite!
|
